结论灯盏花素可有效促进溃疡愈合。
结论灯盏花索可有效治疗后循环缺血。
Conclusion Breviscapine Injection can treat effectively the posterior circulation ischemia.
结论灯盏花素能对抗肾上腺素的升血糖作用。
ConclusionBreviscapine could antagonize Adrena line-induced rise of serum glucose level.
灯盏花注射液对肝损伤病理及生化指标的影响。
Erigeron Injections Effects on Pathologic and Hepatotoxicity Induced By Intestinal Ischemia-Reperfusion in Mice.
目的探讨灯盏花素对顺铂耳蜗毒性的拮抗作用。
Objective it is to discuss the antagonism of breviscapine on cochlea toxicity of Cisplatin.
目的考察处方中组分对灯盏花素分散片制剂的影响。
OBJECTIVE To examine the effects of the ingredients on Breviscarpin dispersed tablet.
目的：观察灯盏花素对肿瘤化疗药物治疗效果的影响。
Objective: To observe the effect of breviscapine on therapeutic efficacy of chemotherapeutic agents for tumors.
目的观察灯盏花素对肾上腺素性高血糖的作用及机制。
ObjectiveTo study the effect and mechanisms of breviscapine on hyperglycemia induced by adrenaline in mice.
方法采用复凝聚法制备了灯盏花素壳聚糖-海藻酸钠微囊。
Methods Breviscapine chitosan-alginate microcapsules were prepared by coacervation technology.
结论：灯盏花素能够缓解组织水肿，保护缺血再灌注骨骼机。
Conclusion: Breviscapine could effectively relieve swelling of soft tissue and protect skeletal muscle from ischemia reperfusion injury.
本发明属药剂领域，涉及灯盏花素口服组合物及其制备方法。
The invention belongs to the field of medicine preparation, which relates to oral breviscapine composition and preparation method thereof.
目的：研究灯盏花乙素苷元对大鼠实验性脑缺血的保护作用。
Objective: To investigate the protective effect of scutellarein on rat cerebral ischemia.
结论优化处方的灯盏花素分散片其体外溶出度明显优于普通片。
CONCLUSION The in-vitro dissolubility of the optimized dispersed tablet is better than that of commontable.
就灯盏花素治疗缺血性脑血管病作用及其机理的进展作一论述。
The article makes review on the mechanism and function of Bre treating ischemia cerebrovascular disease.
目的：探讨灯盏花素对糖尿病大鼠肝、肾组织氧化应激的影响。
AIM: To study the effect of breviscapine on the oxidative stress in the liver and kidney in diabetic rats.
目的探讨灯盏花素对脑缺血再灌注诱导细胞凋亡损伤的保护机制。
OBJECTIVE to study the protective effects of breviscapine on cell apoptosis induced by cerebral ischemia-reperfusion in mice.
目的考察灯盏花素壳聚糖- 海藻酸钠微囊的制备工艺和释药机制。
Objective To investigate the preparation technology and the drug release mechanism of Breviscapine chitosan-alginate microcapsules.
结论：加用灯盏花注射液治疗冠心病比单用常规口服扩冠药疗效更好。
Conclusion: the therapeutic effect of combined use of Dengzhanhua Injection and routine administration of dilational medicine for coronary disease is better than that of the latter alone.
目的探讨灯盏花素对脑缺血再灌注诱导小鼠学习记忆损伤的保护机制。
OBJECTIVE To study the protective effects of breviscapine on learning-memory dysfunction induced by cerebral ischemia-reperfusion in mice.
该方法操作简便、准确，有利于有效控制灯盏花素口服固体制剂质量。
The quality control method is simple, accurate and favorable to effective quality control of the oral breviscapine preparation.
目的研究灯盏花素对沙土鼠缺血再灌注后海马延迟性神经元死亡的影响。
Objective To investigate the protective effect of erigeron on the delayed death of the hippocampal neurons after ischemia reperfusion.
结论灯盏花素可通过抑制神经细胞凋亡而减轻缺血再灌注引起的脑损伤。
CONCLUSION Breviscapine showed an improvement effect against brain impairment induced by ischemia-reperfusion in mice, and the inhibition of apoptosis in brain may be involved in.
目的探讨灯盏花素注射液对家兔缺血再灌注损伤肠系膜微循环的保护作用。
Objective To study the protective effect of breviscapine injection on microcirculation of ischemia-reperfusion injury in mesentery of rabbit.
应用灯盏花素片治疗后，14例P 3潜伏期显著缩短，HDS评分上升。
After breviscapine treatment, P3 latency decreased in 14 patients and HDS increased in all the patients.
结论：灯盏花素可能通过抑制能量代谢障碍、减轻脑水肿而发挥脑保护作用。
CONCLUSION Breviscapine can play a role in protecting brain through inhibiting disorder of energy metabolism and relieving cerebral edema.
方法以崩解时限为指标，采用正交设计试验，对灯盏花素分散片处方进行筛选。
METHODS The formulae of Breviscarpin dispersed tablet were optimized in terms of disintegrating time by orthogonal design test.
目的：研究灯盏花乙素苷元对大鼠血栓形成、血小板聚集和血液流变学的影响。
Objective: To investigate the effects of scutellarein on thrombosis, platelet aggregation and hemorheology in rats.
结果：灯盏花素结构明确，治疗心脑血管疾病疗效显著，已成为中药研发的热点。
RESULT: Breviscapine has clear structure and remarkable effect on cardiovascular diseases, and has been the research hotspot of traditional Chinese medicines.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
目的以羟丙甲基纤维素为骨架材料制得灯盏花素缓释片，并对释药机制进行探讨。
OBJECTIVE Breviscapine sustained-release tablets(BST)were formulated with hydroxypropyl-methylcellulose as the matrix material and the release mechanism of the tablets was studied.
应用推荐